A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor
- PMID: 9769327
- PMCID: PMC508982
- DOI: 10.1172/JCI3795
A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor
Abstract
A single natural loss of function mutation of the follicle stimulating hormone receptor (FSHR) has been described to date. Present in the Finnish population it markedly impairs receptor function, blocking follicle development at the primary stage and presenting as primary amenorrhea with atrophic ovaries. When Western European women with this phenotype were examined for FSHR mutations the result was negative, suggesting that other etiologies corresponding to this clinical pattern are markedly more frequent. We now describe a novel phenotype related to mutations provoking a partial loss of function of the FSHR. A woman with secondary amenorrhea had very high plasma gonadotropin concentrations (especially FSH), contrasting with normal sized ovaries and antral follicles up to 5 mm at ultrasonography. Histological and immunohistochemical examination of the ovaries showed normal follicular development up to the small antral stage and a disruption at further stages. The patient was found to carry compound heterozygotic mutations of the FSHR gene: Ile160Thr and Arg573Cys substitutions located, respectively, in the extracellular domain and in the third intracellular loop of the receptor. The mutated receptors, when expressed in COS-7 cells, showed partial functional impairment, consistent with the clinical and histological observations: the first mutation impaired cell surface expression and the second altered signal transduction of the receptor. This observation suggests that a limited FSH effect is sufficient to promote follicular growth up to the small antral stage. Further development necessitates strong FSH stimulation. The contrast between very high FSH levels and normal sized ovaries with antral follicles may thus be characteristic of such patients.
Similar articles
-
New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype.Mol Endocrinol. 1999 Nov;13(11):1844-54. doi: 10.1210/mend.13.11.0370. Mol Endocrinol. 1999. PMID: 10551778
-
Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies.J Clin Endocrinol Metab. 2003 Aug;88(8):3491-8. doi: 10.1210/jc.2003-030217. J Clin Endocrinol Metab. 2003. PMID: 12915623
-
Molecular pathology of the FSH receptor: new insights into FSH physiology.Mol Cell Endocrinol. 2008 Jan 30;282(1-2):130-42. doi: 10.1016/j.mce.2007.11.027. Epub 2007 Dec 4. Mol Cell Endocrinol. 2008. PMID: 18248882 Review.
-
Functional characterization of two naturally occurring mutations (Val514Ala and Ala575Val) in follicle-stimulating hormone receptor.J Clin Endocrinol Metab. 2015 Apr;100(4):E638-45. doi: 10.1210/jc.2014-3662. Epub 2015 Jan 12. J Clin Endocrinol Metab. 2015. PMID: 25581598
-
Functional and clinical consequences of mutations in the FSH receptor.Mol Cell Endocrinol. 1996 Dec 20;125(1-2):177-82. doi: 10.1016/s0303-7207(96)03949-4. Mol Cell Endocrinol. 1996. PMID: 9027356 Review.
Cited by
-
How genetic errors in GPCRs affect their function: Possible therapeutic strategies.Genes Dis. 2015 Jun;2(2):108-132. doi: 10.1016/j.gendis.2015.02.005. Genes Dis. 2015. PMID: 26229975 Free PMC article.
-
RANKL is a new Epigenetic Biomarker for the Vasomotor Symptom During Menopause.Balkan J Med Genet. 2020 Aug 26;23(1):51-56. doi: 10.2478/bjmg-2020-0001. eCollection 2020 Jun. Balkan J Med Genet. 2020. PMID: 32953409 Free PMC article.
-
Mutations in human gonadotropin and gonadotropin-receptor genes.Endocrine. 2005 Apr;26(3):207-17. doi: 10.1385/ENDO:26:3:207. Endocrine. 2005. PMID: 16034174 Review.
-
Functional characterization of naturally-occurring constitutively activating/inactivating mutations in equine follicle-stimulating hormone receptor.Anim Biosci. 2022 Mar;35(3):399-409. doi: 10.5713/ab.21.0246. Epub 2021 Aug 24. Anim Biosci. 2022. PMID: 34474536 Free PMC article.
-
How polymorphic markers contribute to genetic diseases in different populations? The study of inhibin A for premature ovarian insufficiency.Einstein (Sao Paulo). 2017 Jul-Sep;15(3):269-272. doi: 10.1590/S1679-45082017AO4052. Einstein (Sao Paulo). 2017. PMID: 29091146 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases